A new drug treatment for cancer has produced "highly promising results" in preliminary trials, according to new research published in the prestigious New England Journal of Medicine.
The new cancer drug, called Olaparib, was given to 19 patients with inherited forms of advanced breast cancer, ovarian cancer and prostate cancer caused by mutations of the BRCA1 and BRCA2 genes. With 12 patients - among whom other treatments had failed - cancer tumors shrank or stabilized. In one case, a woman with breast cancer is still in remission two years after being one of the first to be treated with Olaparib.
Read more at The Survivor's Club.
Subscribe to:
Post Comments (Atom)
1 comment:
Yes undoubtedly, in some moments I can reveal that I jibe consent to with you, but you may be inasmuch as other options.
to the article there is still a question as you did in the downgrade efflux of this demand www.google.com/ie?as_q=xilisoft dvd ripper platinum 5.0.28 ?
I noticed the phrase you have not used. Or you partake of the dark methods of development of the resource. I have a week and do necheg
Post a Comment